Why are there Variations in the Responses of Glucagon-like Peptide-1 Agonists among the Type 2 Diabetic Patients?

s Why are there Variations in the Responses of Glucagon-like Peptide-1 Agonists among the Type 2 Diabetic Patients?
By Thekkuttuparambil A. Ajith
Source: Current Clinical Pharmacology, Volume 14, Issue 3, Dec 2019, p. 247 - 248
DOI: https://doi.org/10.2174/157488471403191231143537
- Available online: 01 Dec 2019

There is no abstract available.

Article metrics loading...

/content/journals/ccp/10.2174/157488471403191231143537

2019-12-01

2025-07-07

Full text loading...

/content/journals/ccp/10.2174/157488471403191231143537

s Why are there Variations in the Responses of Glucagon-like Peptide-1 Agonists among the Type 2 Diabetic Patients?